Ameriprise Financial »

First Tracks Biotherapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.9M 193k 20.12

More positions owned by Ameriprise Financial

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Lam Research (LRCX)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Bloom Energy Corp (BE)
iShares S&P 500 Index (IVV)
Micron Technology (MU)
Applied Materials (AMAT)
Facebook Inc cl a (META)
Visa (V)
Alphabet Inc Class C cs (GOOG)

View all positions for Ameriprise Financial

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics